The Daily Startup: IPO Concerns Persist Amid Investor Anxieties
0
Art by Mike Lucas
In this morning’s Web roundup, most newly public companies are trading below their offer prices. Effector Therapeutics raises $56 million as it aims to show that there is another way to develop molecularly targeted oncology products.